AKEBIA THERAPEUTICS, INC. (AKBA) Gross profit 2018–2025
AKEBIA THERAPEUTICS, INC. (AKBA) annual gross profit history from SEC filings — each fiscal year as reported.
$196.7MFY2025 · since FY2018: $200.0M → $196.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $196.7M | +102.8% |
| FY2024 | $97.0M | -19.5% |
| FY2023 | $120.5M | -41.8% |
| FY2022 | $206.9M | +239.3% |
| FY2021 | $61.0M | +3426.7% |
| FY2020 | -$1.8M | -101.0% |
| FY2019 | $189.7M | -5.2% |
| FY2018 | $200.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice